Cited 6 times in
Provisional Guideline Recommendation for EGFR Gene Mutation Testing in Liquid Samples of Lung Cancer Patients: A Proposal by the Korean Cardiopulmonary Pathology Study Group
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 심효섭 | - |
dc.date.accessioned | 2019-07-23T07:01:49Z | - |
dc.date.available | 2019-07-23T07:01:49Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 2383-7837 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/170428 | - |
dc.description.abstract | Liquidbiopsy for detection ofmutationfrom circulating tumor DNA is a new technology which is attractive in that it is non-invasive. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) is an effective first line drug for advanced non-small celllungcancerpatientswho harbor activatingEGFRmutation. During the course of treatment, resistance against TKI arises which can be contributed toEGFRT790Mmutationin about 50-60% ofpatients. Third generation TKI may overcome the resistance. Inpatientswho cannot undergo tissue biopsy due to variable reasons,liquidbiopsy is an excellent alternative for the detection ofEGFRT790Mmutation. However, this relatively novel method requires standardization and vigorous quality insurance. Thus, a standard set ofguidelinerecommendations forliquidbiopsy forEGFRmutationtestingsuitable for theKoreanmedical community is necessary. In this article, we propose a set ofprovisionalguidelinerecommendations that was discussed and approved by theCardiopulmonaryPathologyStudyGroupof theKoreanSociety of Pathologists. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | The Korean Society of Pathologists | - |
dc.relation.isPartOf | JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | Provisional Guideline Recommendation for EGFR Gene Mutation Testing in Liquid Samples of Lung Cancer Patients: A Proposal by the Korean Cardiopulmonary Pathology Study Group | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pathology (병리학교실) | - |
dc.contributor.googleauthor | Dong Hoon Shin | - |
dc.contributor.googleauthor | Hyo Sup Shim | - |
dc.contributor.googleauthor | Tae Jung Kim | - |
dc.contributor.googleauthor | Heae Surng Park | - |
dc.contributor.googleauthor | Yun La Choi | - |
dc.contributor.googleauthor | Wan Seop Kim | - |
dc.contributor.googleauthor | Lucia Kim | - |
dc.contributor.googleauthor | Sun Hee Chang | - |
dc.contributor.googleauthor | Joon Seon Song | - |
dc.contributor.googleauthor | Hyo jin Kim | - |
dc.contributor.googleauthor | Jung Ho Han | - |
dc.contributor.googleauthor | Chang Hun Lee | - |
dc.contributor.googleauthor | Geon Kook Lee | - |
dc.contributor.googleauthor | Se Jin Jang | - |
dc.contributor.googleauthor | Korean Cardiopulmonary Pathology Study Group | - |
dc.identifier.doi | 10.4132/jptm.2019.02.22 | - |
dc.contributor.localId | A02219 | - |
dc.relation.journalcode | J01680 | - |
dc.identifier.eissn | 2383-7845 | - |
dc.identifier.pmid | 30813707 | - |
dc.subject.keyword | Carcinoma, non-small-celllung | - |
dc.subject.keyword | Circulating tumor DNA | - |
dc.subject.keyword | Epidermal growth factor receptor | - |
dc.subject.keyword | Liquidbiopsy | - |
dc.subject.keyword | T790M | - |
dc.contributor.alternativeName | Shim, Hyo Sup | - |
dc.contributor.affiliatedAuthor | 심효섭 | - |
dc.citation.volume | 53 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 153 | - |
dc.citation.endPage | 158 | - |
dc.identifier.bibliographicCitation | JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, Vol.53(3) : 153-158, 2019 | - |
dc.identifier.rimsid | 63018 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.